Marketing

Hot Flush for Big Pharma

The sale of hormone replacement therapy (HRT) to women is a multi-billion dollar cash cow for the pharmaceutical industry. What will its PR machine do in the face of evidence that long-term HRT use increases women's risk of blood clots, strokes, heart attacks, breast cancer, and dementia, and has no quality of life benefits?

No

Free Cigs For Celebs

"A tobacco company is offering a free lifetime supply of cigarettes to celebrity smokers as part of a guerrilla marketing campaign to raise the public profile of its recently launched brand," the Associated Press reports. "In a tersely worded pitch, Freedom Tobacco International Inc. said it was seeking to 'seed' its cigarettes with adult celebrities. The appeal was made Tuesday to publicists through a Web-based network subscribed to by hundreds of public relations agencies. ...

No

Brands On The Run

With international opinion against the United States growing increasingly hostile and economic uncertainty looming at home, U.S. companies are becoming more worried about their appeal abroad. "In an annual survey conducted since 1998, RoperASW has been looking for a connection between the dwindling reputation of America and the worldwide appeal of its top brands, from Disney to Microsoft," Newsweek's Karen Lowry Miller reports.

No

Drug Industry Front Scares Seniors With Radio Ads

A bipartisan group of lawmakers has condemned a radio scare campaign sponsored by the U.S. pharmaceutical industry. "In a bid to defeat legislation that would allow the 'reimportation' of American-made drugs from Canada and Europe, a lobby group calling itself the Seniors Coalition is questioning the safety of Canadian and European prescription drugs," the Toronto Star reports. Reimported drugs are cheaper for seniors to buy. The legislation is part of the $400 billion, 10-year overhaul of the Medicare.

No

Food Industry's PR Offense Against Obesity

"Kraft Foods' recently announced initiatives on obesity have marked a new phase in how food companies will address Americans' concerns about food and nutrition," PR Week writes. Until now, the food industry has tried to deflect the blame for America's growing waistlines by promoting physical activity. Now Kraft and others are talking about changing products and marketing.

No

What Would Jesus (Rivera) Drive?

The industry front group Sport Utility Vehicle Owners of America is striking back at a Christian-sponsored anti-SUV campaign that asked "What Would Jesus Drive?" The Holland (MI) Sentinel reports that SUVOA, which has several hundred members, has created a $17,000 ad that asks, "What Would Jesus (Rivera) Drive?" According to the ad, Rivera drives an SUV because it gets him through the snow in winter, and his wife likes it because she can easily transport their grandchildren.

No
Topics: 

Advertising 'Essential 2' Chemical Industry Image

The American Chemistry Council is considering an advertising campaign by ad giant Ogilvy & Mather "that would convey to the American public how essential the chemical industry is to modern life." The chemical industry trade association saw the campaign proposal, which could cost several hundred thousand dollars, at its recent exclusive membership meeting, reports Michael McCoy in Chemical & Engineer News. Ogilvy's initial market research "shows that the campaign could really 'move the needle' on the public's dim view of the industry. ...

No

Military Recruitment Ads Focus On Parents

The U.S. Department of Defense has launched a new $1.7 million ad campaign designed to convince parents and other adults to encourage young people to join the military. The Washington Times reports that campaign features five successful veterans, highlighting "qualities such as commitment and perseverance" that the vets have gained from service. "We focus on the more emotional aspects the military has to offer," George Rogers, vice president of the agency that created the ads, told the Times.

No

Company Paid Doctors to Promote Drug

"Documents released yesterday in the case of a drug company
whistle-blower shed light on how extensively doctors were
involved in promoting unapproved uses of a Warner-Lambert
drug, Neurontin. Warner-Lambert paid dozens of doctors tens of thousands of dollars each to speak to other physicians about how Neurontin, an epilepsy drug, could be prescribed for more
than a dozen other medical uses that had not been approved
by the Food and Drug Administration. The top speaker for

No

Pages

Subscribe to Marketing